CNTA (NASDAQ: CNTA) insider files Form 144 to sell 120,029 ADRs valued $3.10M
Rhea-AI Filing Summary
CNTA reports a proposed sale of ADRs under Form 144. The filing lists 120,029 ADRs with an aggregate value of $3,103,949.94 and a filing date of 03/13/2026. The notice shows securities tied to an exercise of stock options (109,398 ADRs) on 03/13/2026 and vested RSUs (10,631 ADRs) dated 02/01/2026.
The broker/dealer named is UBS Financial Services Inc. in Weehawken, NJ, and the ADRs are traded on Nasdaq. This Form 144 is a regulatory notice of an intended sale; timing and final execution are determined by the selling holder and market conditions.
Positive
- None.
Negative
- None.
Insights
Form 144 lists a planned sale of 120,029 ADRs valued at $3.10M; proceeds treatment and timing are not set here.
The filing shows 120,029 ADRs with an aggregate value of $3,103,949.94 and identifies an exercise of stock options for 109,398 ADRs dated 03/13/2026. The notice names UBS Financial Services Inc. as the broker/dealer.
Execution depends on holder decisions and market execution; subsequent filings or trade reports would confirm realized sales and proceeds allocation.
This is a routine insider resale notice showing option-derived and RSU-derived ADRs, with no new corporate action disclosed.
The filing enumerates 10,631 ADRs from vested RSUs dated 02/01/2026 and lists Nasdaq as the trading market. There is no internal governance change or transaction condition disclosed in the excerpt.
Impact depends on whether and when the holder sells; the Form 144 itself is an intended-sale disclosure rather than evidence of completed trades.
FAQ
What does CNTA's Form 144 report?
Who is the broker/dealer listed on the CNTA Form 144?
Are the ADRs subject to sale already sold?
What types of securities are being disposed of in the CNTA filing?